Phenomenex competitors

Mark T. Bertolini (born 1956) is an American businessman who was the CEO of Aetna, a Fortune 50 diversified health care benefits company with over $60 billion in 2015 revenue. Bertolini assumed the role of CEO on November 29, 2010 and of Chairman on April 8, 2011 until Aetna was sold to CVS on November 28, 2018.

Mike McMullen is Agilent’s CEO-elect. He will assume the CEO position in March 2015 when William (Bill) Sullivan takes an advisory role until his retirement. As a first step in the CEO transition, McMullen has been named president and chief operating officer. McMullen has more than 30 years of industry experience and senior management experience at Agilent. He has been president of the company’s Chemical Analysis Group (CAG) since 2009, a role he still fills on an acting basis. As head of CAG, McMullen transformed the business, consistently delivering market-leading growth and profits. He championed strategic acquisitions and architected Agilent’s China strategy. He built the Agilent-wide Services business that has now been made one of Agilent’s three major businesses. McMullen has extensive experience working across Agilent’s businesses, and is recognized for his inspirational leadership style. He also has significant international experience, having lived in Japan, leading Agilent’s Japan field sales and support operations, and later adding responsibility for China field operations. McMullen joined Agilent’s predecessor, Hewlett-Packard Co., in 1984 as a financial analyst. He holds a bachelor's degree in economics and business administration from the University of Delaware and an MBA from Wharton Business School.

Growth focused Executive. All things operational. Passionate about culture, inclusion and diversity. Pam is the Chief Executive Officer at Imperva, the cybersecurity leader championing the fight to secure data and applications wherever they reside. Pam was previously Chief Operating Officer at Infor - the world's third largest enterprise software company - headquartered in New York City, providing world-class solutions for specific industries and micro-verticals, serving over 70,000 customers in 125 countries with 18,000 employees across the globe. Prior to Infor, Pam held multiple leadership positions at Oracle Corp (NYSE:ORCL) and prior to that at Andersen Consulting and Arthur Andersen. She is on the Board of Rockwell Automation (NYSE: ROK) and is an investor and advisor to FINTECH start-ups. Pam has 25+ years’ experience spanning finance, field sales, revenue management, cloud product development & architecture, professional services, industry specialization (e.g. Healthcare, Discrete & Process Manufacturing, Services Industries, Hospitality, Public Sector), company turnarounds, setting new high-growth strategy, M&A, business development plus deep operational experience in running global organizations. Public and private company experience. Extensive international experience having held a variety of roles in Europe, Middle East, North America, Australia and New Zealand.

Dr. Singh was elected President and Chief Executive Officer of PerkinElmer effective December 30, 2019, and appointed to our board of directors in August 2019. Previously Dr. Singh was the President and Chief Operating Officer of the Company since January 2019. Dr. Singh joined PerkinElmer as the President of our Diagnostics business in May 2014. He was elected Senior Vice President in September 2016 and Executive Vice President in March 2018. Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare and Philips Healthcare. Earlier in his career, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol-Myers Squibb Medical Imaging, which included managing the Asia Pacific and Middle East region. Dr. Singh holds a doctoral degree in chemistry from the University of Missouri-Columbia and a Master of Business Administration from Northeastern University. His research work has resulted in several issued patents and publications in peer reviewed journals. Dr. Singh has more than twenty-five years of leadership experience with global innovators in healthcare technology. He has spent the most recent six years developing unique insights into both our business and our opportunities for continued growth. Dr. Singh brings to our board a detailed understanding of the core technologies that we utilize and the operational strategies available to us as we continue to focus on innovating for a healthier world.

John Jaufmann is a Chief Executive Officer at Health Plus Advantage, LLC and is based in Palm Harbor, Florida. He has worked as Sr Director Of Government Programs and Markets at Florida Insurance representing Florida Blue (Blue Cross/Blue Shield); CEO at Best Group IPA, Inc.; and Regional Vice President at DaVita. John studied at Empire State College and SUNY College at Old Westbury.

Anders Karl Gustaf Gustafsson (born 7 April 1979 in Jönköping) is a Swedish sprint canoeist who has competed since the mid-2000s. He won four medals at the ICF Canoe Sprint World Championships with a gold (K-1 500 m: 2010) and three silvers (K-1 500 m, K-1 1000 m: both 2009); K-1 1000 m: 2011.

Takaaki Ueda is a Chairman/CEO at SONOSITE INC, Pres & CEO:New Development USA at Fujifilm Holdings, and President/CEO at FUJIFILM Medical Systems USA Inc. He has worked as Gen Mgr:Global Endoscopy Systems at Fujifilm Holdings.